(KLAC) KLA-Tencor - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US4824801009
Stock: Inspection, Metrology, Software, Etch, Deposition
Total Rating 82
Risk 99
Buy Signal 0.31
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.86% |
| Yield on Cost 5y | 2.58% |
| Yield CAGR 5y | 17.37% |
| Payout Consistency | 93.5% |
| Payout Ratio | 20.9% |
| Risk 5d forecast | |
|---|---|
| Volatility | 66.5% |
| Relative Tail Risk | -6.36% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.50 |
| Alpha | 67.23 |
| Character TTM | |
|---|---|
| Beta | 1.765 |
| Beta Downside | 1.510 |
| Drawdowns 3y | |
|---|---|
| Max DD | 34.95% |
| CAGR/Max DD | 1.60 |
Description: KLAC KLA-Tencor January 27, 2026
KLA Corporation (NASDAQ:KLAC) designs, manufactures, and markets process-control and yield-management solutions for the semiconductor and related electronics industries. It operates through three segments-Semiconductor Process Control, Specialty Semiconductor Process, and PCB & Component Inspection-offering tools for defect inspection, metrology, chemical process control, and software that accelerates yield learning and reduces production risk.
In FY 2023 the company generated $9.3 billion in revenue, up 12% year-over-year, driven by strong demand for advanced-node inspection equipment as AI-chip and 3-nm fabs ramp. Gross margin expanded to 53% (vs. 50% in FY 2022) reflecting pricing power in a market where global semiconductor equipment spend is projected to grow 9% CAGR through 2027, according to SEMI. Capital expenditures rose to $1.1 billion, underscoring KLA’s investment in next-generation imaging and AI-enabled metrology platforms.
For a deeper quantitative assessment, see ValueRay’s detailed KLAC model.
Piotroski VR‑10 (Strict, 0-10) 8.0
| Net Income: 4.56b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.26 > 0.02 and ΔFCF/TA 3.78 > 1.0 |
| NWC/Revenue: 55.32% < 20% (prev 51.98%; Δ 3.35% < -1%) |
| CFO/TA 0.29 > 3% & CFO 4.77b > Net Income 4.56b |
| Net Debt (3.83b) to EBITDA (5.91b): 0.65 < 3 |
| Current Ratio: 2.77 > 1.5 & < 3 |
| Outstanding Shares: last quarter (132.2m) vs 12m ago -1.64% < -2% |
| Gross Margin: 61.89% > 18% (prev 0.60%; Δ 6129 % > 0.5%) |
| Asset Turnover: 80.35% > 50% (prev 72.26%; Δ 8.09% > 0%) |
| Interest Coverage Ratio: 19.31 > 6 (EBITDA TTM 5.91b / Interest Expense TTM 285.8m) |
Altman Z'' 6.17
| A: 0.42 (Total Current Assets 11.03b - Total Current Liabilities 3.98b) / Total Assets 16.72b |
| B: 0.17 (Retained Earnings 2.86b / Total Assets 16.72b) |
| C: 0.35 (EBIT TTM 5.52b / Avg Total Assets 15.86b) |
| D: 0.49 (Book Value of Equity 5.47b / Total Liabilities 11.25b) |
| Altman-Z'' Score: 6.17 = AAA |
Beneish M -3.18
| DSRI: 0.74 (Receivables 2.17b/2.49b, Revenue 12.74b/10.84b) |
| GMI: 0.97 (GM 61.89% / 60.28%) |
| AQI: 0.95 (AQ_t 0.24 / AQ_t-1 0.25) |
| SGI: 1.18 (Revenue 12.74b / 10.84b) |
| TATA: -0.01 (NI 4.56b - CFO 4.77b) / TA 16.72b) |
| Beneish M-Score: -3.18 (Cap -4..+1) = AA |
What is the price of KLAC shares?
As of February 07, 2026, the stock is trading at USD 1442.95 with a total of 1,571,403 shares traded.
Over the past week, the price has changed by +1.05%, over one month by +3.44%, over three months by +19.81% and over the past year by +91.03%.
Over the past week, the price has changed by +1.05%, over one month by +3.44%, over three months by +19.81% and over the past year by +91.03%.
Is KLAC a buy, sell or hold?
KLA-Tencor has received a consensus analysts rating of 3.96.
Therefore, it is recommended to buy KLAC.
- StrongBuy: 11
- Buy: 6
- Hold: 10
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the KLAC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 1637.5 | 13.5% |
| Analysts Target Price | 1637.5 | 13.5% |
| ValueRay Target Price | 2301.8 | 59.5% |
KLAC Fundamental Data Overview February 07, 2026
P/E Trailing = 42.0195
P/E Forward = 36.4964
P/S = 14.8763
P/B = 31.9201
P/EG = 2.0892
Revenue TTM = 12.74b USD
EBIT TTM = 5.52b USD
EBITDA TTM = 5.91b USD
Long Term Debt = 5.89b USD (from longTermDebt, last quarter)
Short Term Debt = 51.0m USD (from shortTermDebt, last quarter)
Debt = 6.28b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.83b USD (from netDebt column, last quarter)
Enterprise Value = 190.67b USD (189.59b + Debt 6.28b - CCE 5.21b)
Interest Coverage Ratio = 19.31 (Ebit TTM 5.52b / Interest Expense TTM 285.8m)
EV/FCF = 43.54x (Enterprise Value 190.67b / FCF TTM 4.38b)
FCF Yield = 2.30% (FCF TTM 4.38b / Enterprise Value 190.67b)
FCF Margin = 34.36% (FCF TTM 4.38b / Revenue TTM 12.74b)
Net Margin = 35.76% (Net Income TTM 4.56b / Revenue TTM 12.74b)
Gross Margin = 61.89% ((Revenue TTM 12.74b - Cost of Revenue TTM 4.86b) / Revenue TTM)
Gross Margin QoQ = 61.45% (prev 61.27%)
Tobins Q-Ratio = 11.40 (Enterprise Value 190.67b / Total Assets 16.72b)
Interest Expense / Debt = 1.11% (Interest Expense 69.7m / Debt 6.28b)
Taxrate = 13.88% (184.6m / 1.33b)
NOPAT = 4.75b (EBIT 5.52b * (1 - 13.88%))
Current Ratio = 2.77 (Total Current Assets 11.03b / Total Current Liabilities 3.98b)
Debt / Equity = 1.15 (Debt 6.28b / totalStockholderEquity, last quarter 5.47b)
Debt / EBITDA = 0.65 (Net Debt 3.83b / EBITDA 5.91b)
Debt / FCF = 0.87 (Net Debt 3.83b / FCF TTM 4.38b)
Total Stockholder Equity = 4.79b (last 4 quarters mean from totalStockholderEquity)
RoA = 28.74% (Net Income 4.56b / Total Assets 16.72b)
RoE = 95.22% (Net Income TTM 4.56b / Total Stockholder Equity 4.79b)
RoCE = 51.71% (EBIT 5.52b / Capital Employed (Equity 4.79b + L.T.Debt 5.89b))
RoIC = 44.54% (NOPAT 4.75b / Invested Capital 10.67b)
WACC = 12.05% (E(189.59b)/V(195.87b) * Re(12.42%) + D(6.28b)/V(195.87b) * Rd(1.11%) * (1-Tc(0.14)))
Discount Rate = 12.42% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.50%
[DCF Debug] Terminal Value 68.98% ; FCFF base≈3.97b ; Y1≈4.84b ; Y5≈7.99b
Fair Price DCF = 533.3 (EV 73.74b - Net Debt 3.83b = Equity 69.91b / Shares 131.1m; r=12.05% [WACC]; 5y FCF grow 23.25% → 2.90% )
EPS Correlation: 75.17 | EPS CAGR: 15.65% | SUE: 0.29 | # QB: 0
Revenue Correlation: 73.22 | Revenue CAGR: 10.23% | SUE: 1.31 | # QB: 6
EPS next Quarter (2026-03-31): EPS=9.14 | Chg30d=+0.255 | Revisions Net=+14 | Analysts=24
EPS current Year (2026-06-30): EPS=36.50 | Chg30d=+0.557 | Revisions Net=+13 | Growth EPS=+9.7% | Growth Revenue=+9.6%
EPS next Year (2027-06-30): EPS=45.72 | Chg30d=+3.602 | Revisions Net=+11 | Growth EPS=+25.3% | Growth Revenue=+17.9%
P/E Forward = 36.4964
P/S = 14.8763
P/B = 31.9201
P/EG = 2.0892
Revenue TTM = 12.74b USD
EBIT TTM = 5.52b USD
EBITDA TTM = 5.91b USD
Long Term Debt = 5.89b USD (from longTermDebt, last quarter)
Short Term Debt = 51.0m USD (from shortTermDebt, last quarter)
Debt = 6.28b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.83b USD (from netDebt column, last quarter)
Enterprise Value = 190.67b USD (189.59b + Debt 6.28b - CCE 5.21b)
Interest Coverage Ratio = 19.31 (Ebit TTM 5.52b / Interest Expense TTM 285.8m)
EV/FCF = 43.54x (Enterprise Value 190.67b / FCF TTM 4.38b)
FCF Yield = 2.30% (FCF TTM 4.38b / Enterprise Value 190.67b)
FCF Margin = 34.36% (FCF TTM 4.38b / Revenue TTM 12.74b)
Net Margin = 35.76% (Net Income TTM 4.56b / Revenue TTM 12.74b)
Gross Margin = 61.89% ((Revenue TTM 12.74b - Cost of Revenue TTM 4.86b) / Revenue TTM)
Gross Margin QoQ = 61.45% (prev 61.27%)
Tobins Q-Ratio = 11.40 (Enterprise Value 190.67b / Total Assets 16.72b)
Interest Expense / Debt = 1.11% (Interest Expense 69.7m / Debt 6.28b)
Taxrate = 13.88% (184.6m / 1.33b)
NOPAT = 4.75b (EBIT 5.52b * (1 - 13.88%))
Current Ratio = 2.77 (Total Current Assets 11.03b / Total Current Liabilities 3.98b)
Debt / Equity = 1.15 (Debt 6.28b / totalStockholderEquity, last quarter 5.47b)
Debt / EBITDA = 0.65 (Net Debt 3.83b / EBITDA 5.91b)
Debt / FCF = 0.87 (Net Debt 3.83b / FCF TTM 4.38b)
Total Stockholder Equity = 4.79b (last 4 quarters mean from totalStockholderEquity)
RoA = 28.74% (Net Income 4.56b / Total Assets 16.72b)
RoE = 95.22% (Net Income TTM 4.56b / Total Stockholder Equity 4.79b)
RoCE = 51.71% (EBIT 5.52b / Capital Employed (Equity 4.79b + L.T.Debt 5.89b))
RoIC = 44.54% (NOPAT 4.75b / Invested Capital 10.67b)
WACC = 12.05% (E(189.59b)/V(195.87b) * Re(12.42%) + D(6.28b)/V(195.87b) * Rd(1.11%) * (1-Tc(0.14)))
Discount Rate = 12.42% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.50%
[DCF Debug] Terminal Value 68.98% ; FCFF base≈3.97b ; Y1≈4.84b ; Y5≈7.99b
Fair Price DCF = 533.3 (EV 73.74b - Net Debt 3.83b = Equity 69.91b / Shares 131.1m; r=12.05% [WACC]; 5y FCF grow 23.25% → 2.90% )
EPS Correlation: 75.17 | EPS CAGR: 15.65% | SUE: 0.29 | # QB: 0
Revenue Correlation: 73.22 | Revenue CAGR: 10.23% | SUE: 1.31 | # QB: 6
EPS next Quarter (2026-03-31): EPS=9.14 | Chg30d=+0.255 | Revisions Net=+14 | Analysts=24
EPS current Year (2026-06-30): EPS=36.50 | Chg30d=+0.557 | Revisions Net=+13 | Growth EPS=+9.7% | Growth Revenue=+9.6%
EPS next Year (2027-06-30): EPS=45.72 | Chg30d=+3.602 | Revisions Net=+11 | Growth EPS=+25.3% | Growth Revenue=+17.9%